You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Lidocaine Hydrochloride And Epinephrine, and when can generic versions of Lidocaine Hydrochloride And Epinephrine launch?

Lidocaine Hydrochloride And Epinephrine is a drug marketed by B Braun Medical Inc, Belmora Llc, Eastman Kodak, Hospira, West-ward Pharms Int, and Empi. and is included in fourteen NDAs.

The generic ingredient in LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE is epinephrine; lidocaine hydrochloride. There are twenty-one drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE?
  • What are the global sales for LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE?
  • What is Average Wholesale Price for LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE?
Summary for LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE
Drug patent expirations by year for LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE
Recent Clinical Trials for LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Montefiore Medical CenterN/A
Jessyka LighthallPhase 3
Assiut UniversityN/A

See all LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE clinical trials

Pharmacology for LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE

US Patents and Regulatory Information for LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun Medical Inc LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 208475-001 Sep 8, 2021 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Empi LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE epinephrine; lidocaine hydrochloride SOLUTION;IONTOPHORESIS, TOPICAL 021486-001 Oct 26, 2004 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 089649-001 Jun 21, 1988 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Eastman Kodak LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 040057-002 Feb 26, 1993 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.